SANOFI (SNW.DE) Stock Fundamental Analysis
Europe - FRA:SNW - FR0000120578 - Common Stock
89.65 EUR
-0.4 (-0.44%)
Taking everything into account, SNW scores 6 out of 10 in our fundamental rating. SNW was compared to 54 industry peers in the Pharmaceuticals industry. SNW has an excellent profitability rating, but there are some minor concerns on its financial health. SNW is not valued too expensively and it also shows a decent growth rate. Finally SNW also has an excellent dividend rating. These ratings could make SNW a good candidate for dividend investing.
1. Profitability
1.1 Basic Checks
In the past year SNW was profitable.
In the past year SNW had a positive cash flow from operations.
SNW had positive earnings in each of the past 5 years.
Each year in the past 5 years SNW had a positive operating cash flow.
1.2 Ratios
SNW has a better Return On Assets (11.05%) than 74.07% of its industry peers.
SNW's Return On Equity of 19.73% is fine compared to the rest of the industry. SNW outperforms 62.96% of its industry peers.
Looking at the Return On Invested Capital, with a value of 13.84%, SNW is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for SNW is significantly below the industry average of 14.87%.
The 3 year average ROIC (7.31%) for SNW is below the current ROIC(13.84%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROIC | 13.84% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
1.3 Margins
Looking at the Profit Margin, with a value of 20.35%, SNW is in the better half of the industry, outperforming 75.93% of the companies in the same industry.
SNW's Profit Margin has improved in the last couple of years.
SNW's Operating Margin of 23.59% is in line compared to the rest of the industry. SNW outperforms 57.41% of its industry peers.
SNW's Operating Margin has improved in the last couple of years.
SNW has a Gross Margin (71.70%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of SNW has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% |
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SNW is still creating some value.
Compared to 1 year ago, SNW has about the same amount of shares outstanding.
SNW has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, SNW has an improved debt to assets ratio.
2.2 Solvency
The Debt to FCF ratio of SNW is 2.21, which is a good value as it means it would take SNW, 2.21 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.21, SNW belongs to the top of the industry, outperforming 81.48% of the companies in the same industry.
A Debt/Equity ratio of 0.21 indicates that SNW is not too dependend on debt financing.
SNW has a better Debt to Equity ratio (0.21) than 72.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Altman-Z | N/A |
ROIC/WACC1.79
WACC7.73%
2.3 Liquidity
SNW has a Current Ratio of 1.27. This is a normal value and indicates that SNW is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.27, SNW is in line with its industry, outperforming 40.74% of the companies in the same industry.
SNW has a Quick Ratio of 1.27. This is a bad value and indicates that SNW is not financially healthy enough and could expect problems in meeting its short term obligations.
SNW has a Quick ratio (0.94) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 |
3. Growth
3.1 Past
The earnings per share for SNW have decreased by -5.35% in the last year.
Measured over the past 5 years, SNW shows a small growth in Earnings Per Share. The EPS has been growing by 5.10% on average per year.
Looking at the last year, SNW shows a small growth in Revenue. The Revenue has grown by 2.56% in the last year.
Measured over the past years, SNW shows a small growth in Revenue. The Revenue has been growing by 3.31% on average per year.
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
3.2 Future
Based on estimates for the next years, SNW will show a small growth in Earnings Per Share. The EPS will grow by 7.06% on average per year.
The Revenue is expected to grow by 4.52% on average over the next years.
EPS Next Y3.07%
EPS Next 2Y5.75%
EPS Next 3Y6.01%
EPS Next 5Y7.06%
Revenue Next Year0.53%
Revenue Next 2Y3.48%
Revenue Next 3Y4.4%
Revenue Next 5Y4.52%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 11.80, the valuation of SNW can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of SNW indicates a somewhat cheap valuation: SNW is cheaper than 79.63% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of SNW to the average of the S&P500 Index (25.89), we can say SNW is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 10.44, the valuation of SNW can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SNW indicates a somewhat cheap valuation: SNW is cheaper than 79.63% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of SNW to the average of the S&P500 Index (34.59), we can say SNW is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.8 | ||
| Fwd PE | 10.44 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SNW is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SNW is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.68 | ||
| EV/EBITDA | 11.58 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SNW does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of SNW may justify a higher PE ratio.
PEG (NY)3.85
PEG (5Y)2.31
EPS Next 2Y5.75%
EPS Next 3Y6.01%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.58%, SNW is a good candidate for dividend investing.
SNW's Dividend Yield is rather good when compared to the industry average which is at 2.89. SNW pays more dividend than 90.74% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, SNW pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.58% |
5.2 History
The dividend of SNW has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
SNW pays out 34.82% of its income as dividend. This is a sustainable payout ratio.
SNW's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP34.82%
EPS Next 2Y5.75%
EPS Next 3Y6.01%
FRA:SNW (11/14/2025, 7:00:00 PM)
89.65
-0.4 (-0.44%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners47.5%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap218.39B
Revenue(TTM)66.91B
Net Income(TTM)13.81B
Analysts81.38
Price Target106.41 (18.69%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.58% |
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.82%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.86%
Min EPS beat(2)-2.29%
Max EPS beat(2)6.02%
EPS beat(4)2
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.29%
Max EPS beat(4)14.5%
EPS beat(8)4
Avg EPS beat(8)2.17%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)11
Avg EPS beat(16)3.44%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)3.66%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)5
Avg Revenue beat(12)9.77%
Revenue beat(16)9
Avg Revenue beat(16)21.47%
PT rev (1m)-2.88%
PT rev (3m)-4.83%
EPS NQ rev (1m)-3.95%
EPS NQ rev (3m)-8.32%
EPS NY rev (1m)-1.01%
EPS NY rev (3m)-4.9%
Revenue NQ rev (1m)-1.49%
Revenue NQ rev (3m)-2.89%
Revenue NY rev (1m)0.96%
Revenue NY rev (3m)-0.47%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.8 | ||
| Fwd PE | 10.44 | ||
| P/S | 3.22 | ||
| P/FCF | 21.68 | ||
| P/OCF | 19.19 | ||
| P/B | 3.12 | ||
| P/tB | 23.5 | ||
| EV/EBITDA | 11.58 |
EPS(TTM)7.6
EY8.48%
EPS(NY)8.59
Fwd EY9.58%
FCF(TTM)4.13
FCFY4.61%
OCF(TTM)4.67
OCFY5.21%
SpS27.87
BVpS28.74
TBVpS3.82
PEG (NY)3.85
PEG (5Y)2.31
Graham Number70.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROCE | 16.7% | ||
| ROIC | 13.84% | ||
| ROICexc | 16.48% | ||
| ROICexgc | 66.95% | ||
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% | ||
| FCFM | 14.83% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexgc growth 3Y-13.63%
ROICexgc growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-Score7
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Debt/EBITDA | 0.75 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 58.05% | ||
| Profit Quality | 72.91% | ||
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 | ||
| Altman-Z | N/A |
F-Score7
WACC7.73%
ROIC/WACC1.79
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
EPS Next Y3.07%
EPS Next 2Y5.75%
EPS Next 3Y6.01%
EPS Next 5Y7.06%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
Revenue Next Year0.53%
Revenue Next 2Y3.48%
Revenue Next 3Y4.4%
Revenue Next 5Y4.52%
EBIT growth 1Y15.64%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year30.73%
EBIT Next 3Y13.89%
EBIT Next 5Y11.66%
FCF growth 1Y24.23%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y10.87%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%
SANOFI / SNW.DE FAQ
Can you provide the ChartMill fundamental rating for SANOFI?
ChartMill assigns a fundamental rating of 6 / 10 to SNW.DE.
Can you provide the valuation status for SANOFI?
ChartMill assigns a valuation rating of 5 / 10 to SANOFI (SNW.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for SANOFI?
SANOFI (SNW.DE) has a profitability rating of 7 / 10.
What is the financial health of SANOFI (SNW.DE) stock?
The financial health rating of SANOFI (SNW.DE) is 5 / 10.
What is the expected EPS growth for SANOFI (SNW.DE) stock?
The Earnings per Share (EPS) of SANOFI (SNW.DE) is expected to grow by 3.07% in the next year.